IGF1R and cancer: Notably, the two main receptors of the system, the type I IGF-I receptor (IGF-IR) and the homolog insulin receptor (IR), which occurs in two isoforms (IR-A and IR-B), are often overexpresssed in cancer cells and may affect not only the early phases of carcinogenesis but also cancer progression and cancer resistance to therapies [4–9].